ATP III Update 2004: Implications of Recent Clinical Trials for the ATP III Guidelines

The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001 (Executive Summary published in JAMA, 2001;285:2486-2497). Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therapy. The present document reviews the results of these recent trials and assesses their implications for cholesterol management.

See also:

Development of the Adult Treatment Panel III Update and Financial disclosure of working group members.

NHLBI Clinical Guidelines Development, Statement from Barbara Alving, M.D., Acting Director of the National Heart, Lung, and Blood Institute

NHLBI Responds to CSPI Letter on Cholesterol Guidelines

Origins of the National High Blood Pressure Education Program (NHBPEP) and the National Cholesterol Education Program (NCEP)

2/11/2008 12:13:24 AM     1/16/2008 3:45:18 PM

Related Items:

Third Report of the Expert Panel on Detection, Evaluation, and Treatment of the High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III Final Report)